Third-line systemic treatment in advanced/metastatic gastric cancer: a comprehensive review

The management of advanced gastric cancer has improved over the past decade. There is more evidence to support the efficacy of systemic treatment in refractory gastric cancer beyond second-line treatment. Important randomized controlled trials of chemotherapies, targeted agents and immunotherapies h...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Wing-lok, Lam, Ka-on, So, Tsz-him, Lee, Victor Ho-fun, Kwong, Lai-wan Dora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600493/
https://www.ncbi.nlm.nih.gov/pubmed/31285759
http://dx.doi.org/10.1177/1758835919859990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600493/
https://www.ncbi.nlm.nih.gov/pubmed/31285759
http://dx.doi.org/10.1177/1758835919859990

Ejemplares similares